These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

166 related items for PubMed ID: 16952352

  • 1. Tyrosine residues 654 and 670 in beta-catenin are crucial in regulation of Met-beta-catenin interactions.
    Zeng G, Apte U, Micsenyi A, Bell A, Monga SP.
    Exp Cell Res; 2006 Nov 01; 312(18):3620-30. PubMed ID: 16952352
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Interaction between human-breast cancer metastasis and bone microenvironment through activated hepatocyte growth factor/Met and beta-catenin/Wnt pathways.
    Previdi S, Maroni P, Matteucci E, Broggini M, Bendinelli P, Desiderio MA.
    Eur J Cancer; 2010 Jun 01; 46(9):1679-91. PubMed ID: 20350802
    [Abstract] [Full Text] [Related]

  • 4. Activation of Wnt/beta-catenin pathway during hepatocyte growth factor-induced hepatomegaly in mice.
    Apte U, Zeng G, Muller P, Tan X, Micsenyi A, Cieply B, Dai C, Liu Y, Kaestner KH, Monga SP.
    Hepatology; 2006 Oct 01; 44(4):992-1002. PubMed ID: 17006939
    [Abstract] [Full Text] [Related]

  • 5. MAP kinase and beta-catenin signaling in HGF induced RPE migration.
    Liou GI, Matragoon S, Samuel S, Behzadian MA, Tsai NT, Gu X, Roon P, Hunt DM, Hunt RC, Caldwell RB, Marcus DM.
    Mol Vis; 2002 Dec 20; 8():483-93. PubMed ID: 12500177
    [Abstract] [Full Text] [Related]

  • 6. Hepatocyte growth factor differently influences Met-E-cadherin phosphorylation and downstream signaling pathway in two models of breast cells.
    Matteucci E, Ridolfi E, Desiderio MA.
    Cell Mol Life Sci; 2006 Sep 20; 63(17):2016-26. PubMed ID: 16909210
    [Abstract] [Full Text] [Related]

  • 7. Signalling by neurotrophins and hepatocyte growth factor regulates axon morphogenesis by differential beta-catenin phosphorylation.
    David MD, Yeramian A, Duñach M, Llovera M, Cantí C, de Herreros AG, Comella JX, Herreros J.
    J Cell Sci; 2008 Aug 15; 121(Pt 16):2718-30. PubMed ID: 18664491
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. HGF/c-Met related activation of β-catenin in hepatoblastoma.
    Purcell R, Childs M, Maibach R, Miles C, Turner C, Zimmermann A, Sullivan M.
    J Exp Clin Cancer Res; 2011 Oct 12; 30(1):96. PubMed ID: 21992464
    [Abstract] [Full Text] [Related]

  • 11. Hepatocyte Growth Factor Modulates MET Receptor Tyrosine Kinase and β-Catenin Functional Interactions to Enhance Synapse Formation.
    Xie Z, Eagleson KL, Wu HH, Levitt P.
    eNeuro; 2016 Oct 12; 3(4):. PubMed ID: 27595133
    [Abstract] [Full Text] [Related]

  • 12. Aberrant activation of hepatocyte growth factor/MET signaling promotes β-catenin-mediated prostatic tumorigenesis.
    Aldahl J, Mi J, Pineda A, Kim WK, Olson A, Hooker E, He Y, Yu EJ, Le V, Lee DH, Geradts J, Sun Z.
    J Biol Chem; 2020 Jan 10; 295(2):631-644. PubMed ID: 31819003
    [Abstract] [Full Text] [Related]

  • 13. Oncogenic mutants of RON and MET receptor tyrosine kinases cause activation of the beta-catenin pathway.
    Danilkovitch-Miagkova A, Miagkov A, Skeel A, Nakaigawa N, Zbar B, Leonard EJ.
    Mol Cell Biol; 2001 Sep 10; 21(17):5857-68. PubMed ID: 11486025
    [Abstract] [Full Text] [Related]

  • 14. Activation of c-Met in colorectal carcinoma cells leads to constitutive association of tyrosine-phosphorylated beta-catenin.
    Herynk MH, Tsan R, Radinsky R, Gallick GE.
    Clin Exp Metastasis; 2003 Sep 10; 20(4):291-300. PubMed ID: 12856716
    [Abstract] [Full Text] [Related]

  • 15. beta-Catenin is critical for early postnatal liver growth.
    Apte U, Zeng G, Thompson MD, Muller P, Micsenyi A, Cieply B, Kaestner KH, Monga SP.
    Am J Physiol Gastrointest Liver Physiol; 2007 Jun 10; 292(6):G1578-85. PubMed ID: 17332475
    [Abstract] [Full Text] [Related]

  • 16. Inhibition of junction assembly in cultured epithelial cells by hepatocyte growth factor/scatter factor is concomitant with increased stability and altered phosphorylation of the soluble junctional molecules.
    Pasdar M, Li Z, Marreli M, Nguyen BT, Park M, Wong K.
    Cell Growth Differ; 1997 Apr 10; 8(4):451-62. PubMed ID: 9101091
    [Abstract] [Full Text] [Related]

  • 17. SKI-606 decreases growth and motility of colorectal cancer cells by preventing pp60(c-Src)-dependent tyrosine phosphorylation of beta-catenin and its nuclear signaling.
    Coluccia AM, Benati D, Dekhil H, De Filippo A, Lan C, Gambacorti-Passerini C.
    Cancer Res; 2006 Feb 15; 66(4):2279-86. PubMed ID: 16489032
    [Abstract] [Full Text] [Related]

  • 18. Overexpression of c-met in oral SCC promotes hepatocyte growth factor-induced disruption of cadherin junctions and invasion.
    Murai M, Shen X, Huang L, Carpenter WM, Lin CS, Silverman S, Regezi J, Kramer RH.
    Int J Oncol; 2004 Oct 15; 25(4):831-40. PubMed ID: 15375530
    [Abstract] [Full Text] [Related]

  • 19. WNT-1 and HGF regulate GSK3 beta activity and beta-catenin signaling in mammary epithelial cells.
    Papkoff J, Aikawa M.
    Biochem Biophys Res Commun; 1998 Jun 29; 247(3):851-8. PubMed ID: 9647782
    [Abstract] [Full Text] [Related]

  • 20. Functional and molecular interactions between the HGF/c-Met pathway and c-Myc in large-cell medulloblastoma.
    Li Y, Guessous F, Johnson EB, Eberhart CG, Li XN, Shu Q, Fan S, Lal B, Laterra J, Schiff D, Abounader R.
    Lab Invest; 2008 Feb 29; 88(2):98-111. PubMed ID: 18059365
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.